Analysts Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Price Target at $5.25

Key Points

• Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received an average recommendation of "Hold" from analysts, with ratings that include one sell, three holds, and two buys.
• The average one-year price target for the stock among brokerages is $5.25, with individual targets ranging from $5.00 to $6.00.
• Insiders have sold a total of 7,115,345 shares of the company stock worth approximately $37.8 million over the last three months, indicating potential shifts in ownership interests.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has been assigned an average recommendation of "Hold" from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $5.25.

A number of equities research analysts have issued reports on the company. UBS Group upped their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th. Wall Street Zen downgraded Aveanna Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Friday, June 27th. Truist Financial decreased their price objective on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Barclays started coverage on Aveanna Healthcare in a research report on Wednesday, July 2nd. They set an "equal weight" rating and a $5.50 price objective on the stock. Finally, Jefferies Financial Group upgraded Aveanna Healthcare from a "hold" rating to a "buy" rating and reduced their price target for the stock from $6.25 to $6.00 in a report on Monday, July 21st.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder Robert M. Williams, Jr. sold 750,000 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $5.20, for a total value of $3,900,000.00. Following the completion of the sale, the insider owned 28,890,756 shares of the company's stock, valued at $150,231,931.20. This trade represents a 2.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Patrick A. Cunningham sold 18,500 shares of the firm's stock in a transaction on Friday, June 13th. The stock was sold at an average price of $4.93, for a total value of $91,205.00. Following the completion of the sale, the insider directly owned 327,869 shares of the company's stock, valued at $1,616,394.17. The trade was a 5.34% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,115,345 shares of company stock worth $37,838,057. 7.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Summit Partners L P purchased a new position in Aveanna Healthcare in the second quarter valued at $50,477,000. Jacobs Levy Equity Management Inc. increased its position in Aveanna Healthcare by 50.1% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after purchasing an additional 177,856 shares during the period. Northern Trust Corp increased its position in Aveanna Healthcare by 11.3% during the 4th quarter. Northern Trust Corp now owns 478,907 shares of the company's stock worth $2,189,000 after purchasing an additional 48,572 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of Aveanna Healthcare by 0.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company's stock valued at $2,133,000 after acquiring an additional 4,047 shares during the period. Finally, Millennium Management LLC lifted its position in shares of Aveanna Healthcare by 105.0% during the 4th quarter. Millennium Management LLC now owns 400,374 shares of the company's stock valued at $1,830,000 after acquiring an additional 205,023 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Aveanna Healthcare Trading Down 0.7%

AVAH traded down $0.03 during trading hours on Friday, hitting $3.99. The company's stock had a trading volume of 448,003 shares, compared to its average volume of 389,057. The business's 50-day moving average price is $4.73 and its 200-day moving average price is $4.80. Aveanna Healthcare has a 12 month low of $2.61 and a 12 month high of $6.19. The stock has a market cap of $778.41 million, a price-to-earnings ratio of 199.50 and a beta of 1.98.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.